Transaction #8422 · Form 4 · 0001437749-25-035177
Moleculin Biotech, Inc. · Stock award · Stock Options (right to buy)
Moleculin Biotech, Inc. · Transacted November 12, 2025 · Filed November 14, 2025
What does this filing report?
An SEC Form 4 filing for Moleculin Biotech, Inc. records a stock award involving Stock Options (right to buy) on November 12, 2025. The reported quantity was 150,000. The filing date is November 14, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Moleculin Biotech, Inc.
- Company CIK
- 0001659617
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 150,000
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 164,668
- Ownership description
- Not reported
- SEC acceptance time
- Nov 14, 2025, 4:06 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Cermak Elizabeth ↗
Director
CIK 0001471971
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 150,000
- Conversion / exercise price
- 0.49
- Exercise date
- November 12, 2026
- Expiration date
- November 12, 2035
Filing footnotes & remarks
- F1
- The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
- F2
- The options were issued in connection with the reporting person's Board of Director service to the Company.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.